Back
IGM Biosciences 10K Form
Buy
51
IGMS
IGM Biosciences
Last Price:
10.13
Seasonality Move:
74.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IGMS News And Ratings
See the #1 stock for the next 7 days that we like better than IGMS
IGMS Financial Statistics
Sales & Book Value
Annual Sales: | $2.13M |
---|---|
Cash Flow: | $-38.59M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.07 |
Price / Book: | 5.52 |
Profitability
EPS (TTM): | -3.64000 |
---|---|
Net Income (TTM): | $-220.4M |
Gross Margin: | -- |
Return on Equity: | -110.28% |
Return on Assets: | -52.7% |
IGM Biosciences Earnings Forecast
Key IGM Biosciences Financial Ratios
- The Research & Development expenses have been 10,118.26% of Revenue.
- The Net Earning history of IGMS is -11,568.83% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 2 years.
IGM Biosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | IGMS |
CUSIP: | 449585 |
Website: | igmbio.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 7.06 |
Quick Ratio: | 6.81 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
IGMS Technical Analysis vs Fundamental Analysis
Buy
51
IGM Biosciences (IGMS)
is a Buy
Is IGM Biosciences a Buy or a Sell?
-
IGM Biosciences stock is rated a Buy
The current IGM Biosciences [IGMS] share price is $11.22. The Score for IGMS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.